Clinical Outcomes of COVID-19 Convalescent Plasma According to Treatment Timing and ELISA Antibody Levels: A Real-World Retrospective Cohort Study.

Bayraktar Saral Ö, Yavuz A, Ardıç Ş, Yazıcı T, Özer Yaman S

Open source

DOI
10.3390/medicina62091649
Published
2026 Aug 28
Container
Medicina (Kaunas, Lithuania)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina62091649,
  title = {Clinical Outcomes of COVID-19 Convalescent Plasma According to Treatment Timing and ELISA Antibody Levels: A Real-World Retrospective Cohort Study.},
  author = {Bayraktar Saral Ö and Yavuz A and Ardıç Ş and Yazıcı T and Özer Yaman S},
  year = {2026},
  journal = {Medicina (Kaunas, Lithuania)},
  doi = {10.3390/medicina62091649},
  url = {https://doi.org/10.3390/medicina62091649}
}

RIS

TY  - JOUR
TI  - Clinical Outcomes of COVID-19 Convalescent Plasma According to Treatment Timing and ELISA Antibody Levels: A Real-World Retrospective Cohort Study.
AU  - Bayraktar Saral Ö
AU  - Yavuz A
AU  - Ardıç Ş
AU  - Yazıcı T
AU  - Özer Yaman S
PY  - 2026
JO  - Medicina (Kaunas, Lithuania)
DO  - 10.3390/medicina62091649
UR  - https://doi.org/10.3390/medicina62091649
ER  - 

APA

Ö, B. S., A, Y., Ş, A., T, Y., & S, Ö. Y. (2026). Clinical Outcomes of COVID-19 Convalescent Plasma According to Treatment Timing and ELISA Antibody Levels: A Real-World Retrospective Cohort Study.. Medicina (Kaunas, Lithuania). https://doi.org/10.3390/medicina62091649

Source records